BackGP-Act III Acquisition Overview

GP-Act III Acquisition Total Liabilities

Latest total liabilities for GPAT: $16M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$16.42M
11.49% YoYΔ $1.69M vs prior year quarter

Peer trimmed avg / median

Loading

GP-Act III Acquisition Total Liabilities History

Loading

GP-Act III Acquisition vs. peers: Total Liabilities Comparison

Loading

GP-Act III Acquisition Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GP-Act III Acquisition (GPAT) FAQ

GP-Act III Acquisition posts a total liabilities of $16M as of June 2026. That compares with $15M in the prior-year period — up 11.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, GP-Act III Acquisition's total liabilities was $15M. The latest reading is $16M — a 11.5% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of GP-Act III Acquisition's financial statement story. At $16M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for GPAT's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; GP-Act III Acquisition's other metric pages and overview cover the third.